Vitiligo
Not recruitingStudy on the Effectiveness of Povorcitinib for Adults with Nonsegmental Vitiligo
- Disease:Vitiligo
- Substances:Povorcitinib
Poland- Participants:18–64 years · 65+ years
- Substances:Povorcitinib
- Sponsor:Incyte Corp.
Rare diseases
Investigational molecules
Locations
Back to Poland347 clinical trials in Szczecin, Poland across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
PolandThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on meningococcal and pneumococcal vaccines for infants and toddlers, evaluating both safety profiles and immune responses to protect against serious infections.
Innovative trials examining treatments for inflammatory bowel diseases, including studies on new therapeutic approaches for both ulcerative colitis and Crohn's disease.
Advanced research into treatments for chronic skin conditions, focusing on atopic dermatitis and plaque psoriasis, with multiple studies evaluating novel therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.